Treating XXXX of the sublingual glands, including a useful technique for repair of the floor of the mouth after resection.

@entity1 @entity3975 @entity5 @entity2347 @entity2133 @entity420
BACKGROUND: From a 55-year experience with about 4,000 @entity1 treated for @entity5 , we have identified 18 @entity1 (0.5%) who received definitive treatment for @entity5 arising in the sublingual glands. @entity1 AND METHODS: @entity1 ages ranged from 35 to 76 years (median 59), and @entity1 and @entity1 were equally represented. All had @entity5 , which included @entity2347 (9 @entity1 ), @entity3975 (5 @entity1 ), and @entity420 (4 @entity1 ). An asymptomatic swelling was the most common complaint (7 @entity1 ); the @entity5 was incidentally discovered by a dentist in 4 others. For all @entity1 , the treatment delay ranged from 3 to 24 months, but only 3 had lesions that extended beyond the confines of the floor of the mouth. All were treated surgically by resections, which were peroral in 4 @entity1 , transcervical in 5, and pull-through type (including the submandibular gland) in 7. The remaining 2 @entity1 had composite procedures. In 3 more recently treated @entity1 , pull-through resections were followed by @entity2133 repair involving transmandibular sutures. This technique has proved useful and will be described in detail. RESULTS: Results in this small @entity1 cohort have been most encouraging. Local recurrence occurred in 3 @entity1 who succumbed 11 months, 27 months, and 21 years after initial treatment. Fourteen others remain alive and well 20 months to 20 years (median 74 months) posttreatment, and the remaining @entity1 was recurrence free when he died of unrelated causes 7 years after resection. CONCLUSION: This small experience confirms the rarity of @entity5 and attests to the good results in terms of function and survival that can be anticipated with adequate surgical treatment when the lesion is relatively small.
